Le Lézard
Classified in: Covid-19 virus
Subjects: Stock Sale/Buyback, Share Issue

IGNITE Announces Stock Option Grants and Issuance of Convertible Debenture

Ignite International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) ("IGNITE" or the "Company"), a global consumer packaged goods company, today announced that it has issued options to two of its longest serving directors, Lester Lee and Greg Gilpin-Payne. Mr. Gilpin-Payne and Mr. Lee were each granted options to purchase 100,000 subordinate voting shares of IGNITE, vesting over 3 years at an exercise price of $1.40 per subordinate voting share.

IGNITE also announced that it issued a convertible debenture to International Investments, Ltd. ("International") in the amount of $5,513,644.26 on December 16, 2021, with an exercise price of $1.40 and maturity date of March 31, 2023. The convertible debenture extinguishes and replaces three promissory notes that the Company issued to International over the past six months.

Dan Bilzerian, CEO at IGNITE, stated, "As we finish what will be an extraordinary turnaround year at IGNITE, I wish to thank the entire management team, the Board of Directors and our dedicated employees for a great effort. I also wish to recognize and thank some of our unpaid consultants who have given their time and invaluable advice to help IGNITE over the past fifteen months. David Bell has given guidance and advice to our sales team which has helped IGNITE achieve several record-breaking quarters of sales. Scott Rohleder has given guidance and advice to our finance team and is currently serving as Acting Chief Financial Officer. And last, but not least, my father, Paul Bilzerian, has given guidance and advice with respect to legal, finance, and general management issues. Although none of them has any obligation to continue providing the Company with their unpaid services, they have all indicated their intention to continue through 2022."

John Schaefer, IGNITE's President and Chief Operating Officer, stated, "I agree with Dan that the management team, Board of Directors, our dedicated employees, and consultants have worked very hard to make 2021 a highly successful year for IGNITE. It is our belief that 2022 will be an even greater year."


IGNITE is a global consumer premium brand, operating in several market segments. IGNITE product categories include CBD products, nicotine and synthetic nicotine vape products, premium performance drinks named ZRO, apparel, and spirits featuring tequila and a premium vodka.

Shares of IGNITE are listed on the Canadian Securities Exchange (CSE) under the symbol "BILZ" and quoted in the United States on the OTCQX under the symbol "BILZF".

Further information on IGNITE can be found on the Company's website at www.ignite.co.


This news release includes certain "forward?looking statements" under applicable Canadian securities legislation, including the future performance of the Company in 2022 and the continued services provided by the named consultants. Forward?looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward?looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the effects and impacts of the coronavirus disease (COVID?19) pandemic, the extent and duration of which are uncertain at this time on IGNITE's business, and general economic and business conditions. There can be no assurance that any of the forward?looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward?looking statements. The Company disclaims any intention or obligation to update or revise any forward?looking statements, whether because of new information, future events or otherwise, except as required by law.

These press releases may also interest you

at 14:00
The "Indian Passenger Vehicle Outlook, 2022" report has been added to  ResearchAndMarkets.com's offering. The research service covers current market size and segmentation of the PV industry; it also covers the rate at which the automotive industry is...

at 14:00
With the submission deadline approaching, the Biocodex Microbiota Foundation is calling for final grant applications from early-career investigators studying gut microbiota in human health and disease, including Covid-19, sleep disorders, the...

at 13:15
The "Clinical Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to  ResearchAndMarkets.com's offering. The global clinical diagnostics market size reached US$ 71.39 Billion in...

at 13:05
N-iX, a leading global software development service company, today released its 2021-2022 Sustainability Report. The report outlines the company's ongoing commitment to corporate social responsibility and highlights five impact areas: People at...

at 13:00
The "Head and Neck Cancer Therapeutics: Global Markets" report has been added to  ResearchAndMarkets.com's offering. This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of...

at 12:45
The "Bamboos Market By Species, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to  ResearchAndMarkets.com's offering. The global bamboos market size was valued at $65,829.6 million in 2021, and is...

News published on 21 december 2021 at 09:35 and distributed by: